𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Confirmation of the Mantle-Cell Lymphoma International Prognostic Index in Randomized Trials of the European Mantle-Cell Lymphoma Network

✍ Scribed by Hoster, E.; Klapper, W.; Hermine, O.; Kluin-Nelemans, H. C.; Walewski, J.; van Hoof, A.; Trneny, M.; Geisler, C. H.; Di Raimondo, F.; Szymczyk, M.; Stilgenbauer, S.; Thieblemont, C.; Hallek, M.; Forstpointner, R.; Pott, C.; Ribrag, V.; Doorduijn, J.; Hiddemann, W.; Dreyling, M. H.; Unterhalt, M.

Book ID
125490218
Publisher
American Society of Clinical Oncology
Year
2014
Tongue
English
Weight
343 KB
Volume
32
Category
Article
ISSN
0732-183X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Validation of the mantle cell lymphoma i
Validation of the mantle cell lymphoma international prognostic index: A single-center retrospective analysis
✍ Stephen D. Smith; Eric Hsi; Brian Bolwell; Brad Pohlman; Robert Dean; Meagan Eff πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 317 KB πŸ‘ 2 views

Mantle cell lymphoma (MCL) is a unique, recently recognized entity with a variable clinical course [1]. Its historical grouping as an indolent lymphoma belies its common behavior, which is generally aggressive and incurable, with a median survival of about 5 years with modern therapy [2]. In an effo